-
Lori E. Hammond
Member
Louisville, KY
Member
Louisville, KY
Lori focuses her practice on the defense of medical device and pharmaceutical drug manufacturers in litigation nationally, regionally and throughout Kentucky. She is co-chair of the firm’s drug and medical device practice group.  Lori understands her clients’ products, their businesses and the regulatory structure that governs them. This knowledge allows her to properly evaluate the client’s needs and develop creative and effective strategies for resolving litigation. She has had significant success in disposing of claims on summary judgment based on federal preemption, causation, as well as lack of product defect. Lori is experienced in creating pre-litigation document retention procedures and developing production strategies for large litigation document projects for geographically diverse clients.
Her medical device and pharmaceutical experience includes: transvaginal mesh, drug eluting stents, bare metal stents, insulin infusion pumps, knee replacement systems, orthopedic bone screws, absorbable and non-absorbable surgical sutures, bone anchors, cardiac catheters, cardiac ablation percutaneous catheters, mechanical heart valves, defibrillators, robotic-assisted surgical systems, bipolar coagulator system, Risperidone, Infliximab, Cerivastatin, Pramipexole, and Propoxyphene.  Lori has also represented product manufacturers from a broad range of industries in the toxic tort arena. Lori’s toxic tort experience includes: lead paint, transuranics, silica, carbon monoxide and asbestos.
Defense of transvaginal mesh manufacturer in litigation stemming from placement of mesh for the treatment of stress urinary incontinence and pelvic organ prolapse.
Defense of drug eluting stent manufacturers in litigation involving alleged injuries from the devices including prolonged use of antithrombotic medications, hypersensitivity reactions and occlusion of the devices.
Defense of a pharmaceutical company in litigation stemming from adolescent use of antipsychotic medication allegedly resulting in permanent dystonia.
Defense of a manufacturer of polyurethane foam in litigation stemming from the Rhode Island Station Club fire. Involving one hundred deaths and hundreds of injuries.
Defense of a pharmaceutical company in a wrongful death case alleging injuries and ultimately death from the use of Infliximab to treat ulcerative colitis.
Defense of a government contractor in several putative class action lawsuits arising from alleged exposure to high levels of uranium and uranium contaminants at the Paducah Gaseous Diffusion Plant in Paducah, Kentucky stemming from the client’s operation of a nuclear processing facility in Hanford, Washington.
Defense of international paint manufacturer in serial litigation involving the manufacture of “lead products” that were used in paint, or succeeded in interest to such manufacturers, and applied to the interior of dwellings.
Defense of multinational explosives and chemicals producer in civil litigation arising from the terrorist attack on the Oklahoma City Federal building.
University of Louisville, Louis D. Brandeis School of Law, J.D., 1995
University of Kentucky, B.A., 1991
United States Supreme Court
U.S. District Court for the Eastern District of Kentucky
U.S. District Court for the Western District of Kentucky
Third Circuit
Sixth Circuit
Seventh Circuit
Eighth Circuit
Tenth Circuit
